Fondaparinux

Red

Brand Name(s):Arixtra

Indication:Acute DVT and PE, and prevention of VTE in high-risk patients. Acute symptomatic spontaneous superficial vein thrombosis of the lower limbs without concomitant deep vein thrombosis.

Rationale:1,2

Considered:Feb-07

Review Date:Mar-22

Comments:
NICE Clinical Guideline 92
Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital January 2010